Aurinia Pharmaceuticals Inc. (AUPH)
Data as of , from SEC Form 4 filings.
Net insider selling (90d)Watch AUPH
See up to 3 months of AUPH. The 7-day demo opens the 1M and 3M ranges and puts AUPH on your watchlist.
Start 7-day demoLatest AUPH insider trades
About Aurinia Pharmaceuticals Inc. (AUPH)
The SEC lists Aurinia Pharmaceuticals Inc. under CIK 0001600620, in pharmaceutical preparations. It is grouped with Health Care companies on this site.
AUPH Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 2 | 32,914 | $546K |
AUPH insider transactions (Form 4)
5735 Form 4 filings on record, the earliest from Nov 12, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Stephen P. Robertson - Officer | Open-market sale | Common Stock | 11,939 footnote F1 | $15.95 footnote F2 | $190K | |
| ||||||
| Stephen P. Robertson - Officer | Open-market sale | Common Stock | 20,975 footnote F1 | $16.97 footnote F2 | $356K | |
| ||||||
| Craig A. Johnson - Director | Grant or award | Director Stock Option (right to buy) | 23,931 | $0.00 | - | |
| Kathleen Goetz - Director | Grant or award | Director Stock Option (right to buy) | 23,931 | $0.00 | - | |
| Tina Susan Nova - Director | Grant or award | Director Stock Option (right to buy) | 23,931 | $0.00 | - | |
| Jeffrey Allen Bailey - Director | Grant or award | Director Stock Option (right to buy) | 23,931 | $0.00 | - | |
 Kevin Tang - Officer | Open-market purchase | Common Shares | 2,299 | $15.35 footnote F1 | $35K | |
| Kevin Tang - Officer | Open-market purchase | Common Shares | 262,682 | $15.31 footnote F3 | $4.02M | |
| Kevin Tang - Officer | Open-market purchase | Common Shares | 343,521 | $15.28 footnote F4 | $5.25M | |
| Kevin Tang - Officer | Open-market purchase | Common Shares | 99 | $15.34 footnote F5 | $2K | |
| Kevin Tang - Officer | Open-market purchase | Common Shares | 206,005 | $15.28 footnote F6 | $3.15M | |
| Kevin Tang - Officer | Other | Short Put Options (potential obligation to buy) | 10,000 | $1.65 | $17K | |
| ||||||
| Stephen P. Robertson - Officer | Grant or award | Common Stock | 115,541 footnote F1 | $0.00 | - | |
| ||||||
| Michael S. Hearne - Officer | Grant or award | Common Stock | 116,144 footnote F1 | $0.00 | - | |
| Michael S. Hearne - Officer | Grant or award | Employee Stock Option (right to buy) | 70,230 | $0.00 | - | |
| ||||||
 Ryan Cole - Officer | Grant or award | Common Stock | 116,144 footnote F1 | $0.00 | - | |
| Ryan Cole - Officer | Grant or award | Employee Stock Option (right to buy) | 70,230 | $0.00 | - | |
| ||||||
| Greg Keenan - Officer | Tax withholding / forfeiture | Common Stock | 8,069 footnote F1 | $14.32 | $116K | |
| ||||||
| Kevin Tang | Open-market purchase | Common Shares | 115,792 | $14.21 footnote F6 | $1.65M | |
| Kevin Tang | Open-market purchase | Common Shares | 184,208 | $14.22 footnote F7 | $2.62M | |
| Kevin Tang | Open-market purchase | Common Shares | 300,000 | $13.90 footnote F1 | $4.17M | |
| Kevin Tang | Open-market purchase | Common Shares | 214,839 | $14.12 footnote F3 | $3.03M | |
| Kevin Tang | Open-market purchase | Common Shares | 1,600 | $14.38 footnote F4 | $23K | |
| Kevin Tang | Open-market purchase | Common Shares | 83,561 | $14.33 footnote F5 | $1.20M | |
| ||||||
| Joseph M. Miller - Officer | Grant or award | Common Stock | 57,229 footnote F1 | $0.00 | - | |
| Joseph M. Miller - Officer | Tax withholding / forfeiture | Common Stock | 37,511 footnote F2 | $14.21 | $533K | |
| Joseph M. Miller - Officer | Grant or award | Employee Stock Option (right to buy) | 95,700 | $0.00 | - | |
| ||||||
| Matthew Maxwell Donley - Officer | Grant or award | Common Stock | 58,160 footnote F1 | $0.00 | - | |
| Matthew Maxwell Donley - Officer | Tax withholding / forfeiture | Common Stock | 40,761 footnote F2 | $14.21 | $579K | |
| Matthew Maxwell Donley - Officer | Grant or award | Employee Stock Option (right to buy) | 97,256 | $0.00 | - | |
| ||||||
| Peter Greenleaf - Officer | Grant or award | Common Stock | 196,403 footnote F1 | $0.00 | - | |
| Peter Greenleaf - Officer | Tax withholding / forfeiture | Common Stock | 100,890 footnote F2 | $14.21 | $1.43M | |
| Peter Greenleaf - Officer | Grant or award | Employee Stock Option (right to buy) | 328,424 | $0.00 | - | |
| ||||||
| Greg Keenan - Officer | Grant or award | Common Stock | 40,586 footnote F1 | $0.00 | - | |
| Greg Keenan - Officer | Grant or award | Employee Stock Option (right to buy) | 67,870 | $0.00 | - | |
| ||||||
| Stephen P. Robertson - Officer | Grant or award | Common Stock | 59,090 footnote F1 | $0.00 | - | |
| Stephen P. Robertson - Officer | Tax withholding / forfeiture | Common Stock | 36,525 footnote F2 | $14.21 | $519K | |
| Stephen P. Robertson - Officer | Grant or award | Employee Stock Option (right to buy) | 98,813 | $0.00 | - | |
| ||||||
| Matthew Maxwell Donley - Officer | Tax withholding / forfeiture | Common Stock | 32,901 footnote F1 | $14.40 | $474K | |
| ||||||
| Peter Greenleaf - Officer | Tax withholding / forfeiture | Common Stock | 100,171 footnote F1 | $14.40 | $1.44M | |
| ||||||
| Joseph M. Miller - Officer | Tax withholding / forfeiture | Common Stock | 32,424 footnote F1 | $14.40 | $467K | |
| ||||||
| Stephen P. Robertson - Officer | Tax withholding / forfeiture | Common Stock | 34,638 footnote F1 | $14.40 | $499K | |
| ||||||
| Greg Keenan - Officer | Tax withholding / forfeiture | Common Stock | 11,552 footnote F1 | $14.53 | $168K | |
| ||||||
| Jeffrey Allen Bailey - Director | Tax withholding / forfeiture | Common Shares | 2,716 footnote F1 | $15.68 | $43K | |
| ||||||
| Craig A. Johnson - Director | Tax withholding / forfeiture | Common Shares | 6,039 footnote F1 | $15.68 | $95K | |
| ||||||
| Kevin Tang | Open-market purchase | Common Shares | 1,000,000 | $10.12 | $10.12M | |
| Kevin Tang | Open-market purchase | Common Shares | 100,000 | $11.34 | $1.13M | |
| Kevin Tang | Open-market purchase | Common Shares | 200,000 | $11.68 | $2.34M | |
| Greg Keenan - Officer | Open-market sale | Common Stock | 20,000 | $10.50 | $210K | |
| Tina Susan Nova - Director | Grant or award | Director Stock Option (right to buy) | 63,724 | $0.00 | - | |
| Kevin Tang | Open-market purchase | Common Shares | 300,000 | $8.91 | $2.67M | |
| Kevin Tang | Open-market purchase | Common Shares | 400,000 | $9.01 | $3.60M | |
| Kevin Tang | Open-market purchase | Common Shares | 500,000 | $9.09 | $4.54M | |
| Karen L. Smith - Director | Grant or award | Common Shares | 12,135 | $0.00 | - | |
| Karen L. Smith - Director | Grant or award | Director Stock Option (right to buy) | 18,641 | $0.00 | - | |
| Jill Leversage - Director | Grant or award | Common Shares | 12,135 | $0.00 | - | |
| Jill Leversage - Director | Grant or award | Director Stock Option (right to buy) | 18,641 | $0.00 | - | |
Item 8.01
Item 2.02, 9.01
Item 5.07, 9.01
Item 2.01, 9.01
Recent AUPH Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Stephen P. Robertson | Officer | 47,000 | $719K | View on EDGAR | |
| - | - | - | - |
AUPH insider trading FAQ
What is the latest insider trade for AUPH?
Aurinia Pharmaceuticals Inc. (AUPH) had 2 insider filings in the last 90 days, with the most recent on 2026-09-11. The full record for AUPH runs to 35 Form 4 filings, the earliest from 2024-11-12. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying AUPH stock?
No insider purchases of AUPH were filed in the last 90 days. 17 purchases are on record for this company.
How many insiders are selling AUPH stock?
2 insider sales of AUPH were filed in the last 90 days, totaling $546K.
Where can I see AUPH SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects AUPH Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Stephen P. Robertson view on EDGAR
- - Stephen P. Robertson view on EDGAR
- - Craig A. Johnson view on EDGAR
- - Kathleen Goetz view on EDGAR
- - Tina Susan Nova view on EDGAR
- - Jeffrey Allen Bailey view on EDGAR
- - Kevin Tang view on EDGAR
- - Stephen P. Robertson view on EDGAR
- - Michael S. Hearne view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where AUPH's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow AUPH with a 7-day demo
- AUPH on your watchlist
- Every AUPH Form 4 filing on record
- Up to 3 months of AUPH price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
